We emphasize that in the pneumonia caused by CA-SA, the control of inflammation is as important as the anti-infection strategy, and that inhibition of the NLRP3 inflammasome may serve as a mechanism for severe acute S. aureus pneumonia adjuvant therapy. The gene discussed is NLRP3; the disease is infection.